Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-06-08 09:17 am Sale | 13D | Satsuma Pharmaceuticals Inc. STSA | Shin Nippon Biomedical Laboratories Ltd. | 1,000 100.000% | -2,793,113 (-99.96%) | View |
| 2023-04-17 4:09 pm Unchanged | 13D | Satsuma Pharmaceuticals Inc. STSA | Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.400% | 0 (Unchanged) | View |
| 2022-08-12 06:44 am Purchase | 13D | Wave Life Sciences Ltd. WVE | Shin Nippon Biomedical Laboratories Ltd. | 9,666,408 10.600% | 3,771,930 (+63.99%) | View |
| 2021-03-31 08:52 am Purchase | 13D | Satsuma Pharmaceuticals Inc. STSA | Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.900% | 2,794,113 (New Position) | View |